Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2000
05/04/2000WO2000024409A1 Composition containing eugenol and polyphenols and use of such a composition for wound healing
05/04/2000WO2000024401A1 Fluticasone lotion having improved vasoconstrictor activity
05/04/2000WO2000024400A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof
05/04/2000WO2000024391A2 Conductance of improperly folded proteins through the secretory pathway
05/04/2000WO2000024386A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000WO2000024385A1 Tablet for crunching with masked taste and instant release of active principle and method for making same
05/04/2000WO2000024383A1 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor
05/04/2000WO2000024382A2 Method for producing solid spherical materials containing a biologically active substance
05/04/2000WO2000024381A1 Divisible tablet
05/04/2000WO2000024380A1 Microparticles containing peg and/or peg glyceryl esters
05/04/2000WO2000024379A1 Process for producing spherical fine particles containing drug
05/04/2000WO2000024378A1 Compositions of microspheres for wound healing
05/04/2000WO2000024377A1 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
05/04/2000WO2000024376A1 Propofol composition
05/04/2000WO2000024374A1 Controlled release liquid delivery compositions with low initial drug burst
05/04/2000WO2000024373A1 O/w emulsion comprising an hydroxylated oil
05/04/2000WO2000024366A1 Preparations for topical application of substances having antiandrogenic effect
05/04/2000WO2000024362A2 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use
05/04/2000WO2000024360A2 Preparation and use of solidified oils
05/04/2000WO2000024267A1 Gelatins with low allergenicity
05/04/2000WO2000012072A3 The use of fumaric acid derivatives in transplant medicine
05/04/2000WO2000006579A3 Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity
05/04/2000WO2000006204A3 Genetically engineered cells and tissues
05/04/2000WO2000004876A8 Controlled release of bioactive substances
05/04/2000WO2000004862A3 Bioenhanced formulations comprising eprosartan in oral solid dosage form
05/04/2000WO2000003753A3 Microdisperse drug delivery systems
05/04/2000WO2000003677A3 Use of bisphosphonates in the treatment of vascular restenosis
05/04/2000WO1999065452A9 Hydrogels of water soluble polymers crosslinked by protein domains
05/04/2000WO1999059573A9 Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
05/04/2000WO1998025595A3 Aqueous drink composition comprising ibuprofen
05/04/2000DE19850517A1 Vorrichtung für eine transdermale und phonophoretische Kombinationsbehandlung und ihre Verwendung in einem Verfahren zur medizinischen Anwendung Device for transdermal and phonophoretische combination treatment and their use in a method of medical application
05/04/2000DE19850445A1 Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen Drugs for the topical treatment of inflammatory bowel disease
05/04/2000DE19850309A1 Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer Expandable system gastroretensives therapy with prolonged gastric residence
05/04/2000DE19849848A1 Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung Administered Orally, with liquid spontaneously disintegrating therapeutic dosage form and process for their preparation
05/04/2000DE19849823A1 Self adhesive, dermal or transdermal plaster for direct application of active agent from reservoir layer on contact with skin
05/04/2000DE19849434A1 Teilbare Tablette Divisible tablet
05/04/2000CA2348529A1 Conductance of improperly folded proteins through the secretory pathway
05/04/2000CA2348452A1 Microparticles containing peg and/or peg glyceryl esters
05/04/2000CA2348281A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof
05/04/2000CA2347967A1 Substance for reduction of cholesterol as well as lipids content
05/04/2000CA2347911A1 Single morphic forms of known peptide metalloproteinase inhibitors
05/04/2000CA2347775A1 Process for producing spherical fine particles containing drug
05/04/2000CA2347109A1 Fluticasone lotion having improved vasoconstrictor activity
05/04/2000CA2347107A1 Bone-pathobolism treating agent
05/04/2000CA2347032A1 O/w emulsion comprising an hydroxylated oil
05/04/2000CA2347028A1 Systems and compounds for drug delivery to interstitial regions of the myocardium
05/04/2000CA2346820A1 Preparation and use of solidified oils
05/04/2000CA2344637A1 .delta.9 tetrahydrocannabinol (.delta.9 thc) solution metered dose inhalers and methods of use
05/04/2000CA2343100A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs
05/04/2000CA2342337A1 Vaporizing device for administering sterile medication
05/04/2000CA2340226A1 Preservative system for topically administrable pharmaceutical compositions
05/03/2000EP0997153A1 Formulations for lipophilic compounds
05/03/2000EP0997151A2 Method for administering insulinotropic peptides
05/03/2000EP0997148A1 Phosphate-binding polymer preparations
05/03/2000EP0997144A1 Plasticizer and patch containing the plasticizer
05/03/2000EP0997143A2 Soft chewable tablets
05/03/2000EP0996673A1 Starch-based thermoplastic mixture containing at least one cationic starch and at least one anionic starch, method for producing the mixture, and use of the same
05/03/2000EP0996508A1 Film coatings and film coating compositions based on dextrin
05/03/2000EP0996466A2 Novel composition comprising an ssri and a beta-blocker
05/03/2000EP0996465A1 Compositions and articles for reducing the effects of inflammation
05/03/2000EP0996453A1 Methods for the inhibition of neuronal activity by local delivery of adenosine
05/03/2000EP0996452A2 A process for the preparation of solid oral dosage forms comprising alendronic acid
05/03/2000EP0996449A1 Pharmaceutical compositions comprising cefuroxime axetil
05/03/2000EP0996447A1 Combination therapy for modulating the human sexual response
05/03/2000EP0996442A1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
05/03/2000EP0996437A1 Semisolid pharmaceutical formulation containing dexketoprofen trometamol
05/03/2000EP0996436A1 Pharmaceutical formulations containing poorly soluble drug substances
05/03/2000EP0996431A1 Synergistic compositions of lycopene and vitamin e for the prevention of ldl oxidation
05/03/2000EP0996429A1 Solid state solutions and dispersions of poorly water soluble drugs
05/03/2000EP0996428A2 Topical application of a combination of benzoyl peroxide and a second active ingredient
05/03/2000EP0996427A1 Process for improving flow and compression of tableting compositions
05/03/2000EP0996426A1 Multiphase system
05/03/2000EP0996425A2 A delivery system for an oral care substance using a strip of material having low flexural stiffness
05/03/2000EP0996424A1 Solid pharmaceutical preparation
05/03/2000EP0996423A1 A method for producing jelly sweets which contain antibodies
05/03/2000EP0996407A1 Adhesive plaster with microcapsules containing essences, and method for its preparation
05/03/2000EP0961801A4 Monomers derived from hydroxy acids and polymers prepared therefrom
05/03/2000EP0862419B1 Microencapsulated dna for vaccination and gene therapy
05/03/2000EP0722314B1 Pellet for administration to ruminants
05/03/2000EP0711151B1 Particles with modified physicochemical properties, their preparation and uses
05/03/2000EP0688206B1 Vaccine delivery system and shelf-stable precursor solution for remote encapsulation of active ingredients
05/03/2000EP0682512B1 Alkaline ophthalmic suspensions
05/03/2000EP0625055B1 Use of fullerenes in diagnostic and/or therapeutic agents
05/03/2000EP0585436B1 Immobilization of chemical species in crosslinked matrices
05/03/2000EP0569408B1 Wet powder film-forming compositions
05/03/2000CN1252005A Pressure-sensitive adhesives for percutaneous plasters and percutaneous plasters
05/03/2000CN1252004A Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition
05/03/2000CN1252003A Solvent system for enhanced penetration of pharmaceutical compounds
05/03/2000CN1252001A Method for destroying retinal pigment epithelial cells
05/03/2000CN1252000A Pharmaceutical compositions having appetite suppressant activity
05/03/2000CN1251994A Extended release formulations of erythromycin derivatives
05/03/2000CN1251990A Pharmaceutical formulations comprising amoxocyllin and clavulanate
05/03/2000CN1251988A Adherent microcapsules containing biologically active ingredients
05/03/2000CN1251987A Dasage forms comprising separate portions of R- and S-enantiomers
05/03/2000CN1251986A Diffusional implantable delivery system
05/03/2000CN1251985A Cosmetic and dermatological agent with hard-magnetic particle base
05/03/2000CN1251984A Spray compositions
05/03/2000CN1251983A Spray compositions
05/03/2000CN1251979A Controlled release of pharmaceuticals in antiterior chamber of eye
05/03/2000CN1251969A Method for treating parillomarvirus infections
1 ... 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 ... 2991